• Home
  • Oxford-AstraZeneca

EU agrees potential 1.8 billion-dose purchase of Pfizer jab

Oxford-AstraZeneca jabs effective against severe COVID-19, new trial in US confirms

Nepal gives emergency use approval to Bharat Biotech’s Covaxin

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 trials

18-19 anti-COVID-19 vaccines in pipeline says Health Min Vardhan

South Africa suspends AstraZeneca vaccine drive

COVID-19 vaccines sent by India reach Bhutan and Maldives

UK approval of Oxford-AstraZeneca COVID-19 vaccine positive news, waiting for India’s approval: SII

Oxford-AstraZeneca’s COVID vaccine can be available in 1st half of next year: Official

Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

Serum Institute seeks emergency use authorisation for Covishield vaccine in India

Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

KEM Hospital starts trials of Oxford-AstraZeneca Covid-19 vaccine candidate in Mumbai

Latest Additions

Puttur: Illegal transportation of cows; three arrested

Cong postpones mega rally against price rise in Delhi to Sep 4

UP: CM Adityanath expresses displeasure over delay in development projects

K’taka Waqf board demands permission to celebrate Eid Milad on lines of Ganesh festival in schools

SC orders status quo, says Delhi HC-appointed CoA will not take over affairs of IOA

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.